ArticleAnnals of African medicine2026
Impact of Adding a Millet Diet on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus.
Article in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextMillets contain complex carbs, which are "good" kinds of carbs. These carbs do not propel blood sugar to rise to a dangerous extent. These findings should provide insight into the possibility of ameliorating type 2 diabetes through diet modulation.
aimsThis study aims to study the effect of millet intake on glycemic control and lipid profile on patients of type 2 diabetes mellitus. SETTINGS AND
designThis study was a cross-sectional study. MATERIALS AND
methodsAfter following the inclusion and exclusion criteria, study participants were enrolled. Baseline glycated hemoglobin (HbA1c) and lipid profile were recorded at day zero. A booklet on millet uses and its benefits on glycemic control were provided to the patients in their vernacular language. A daily diary was provided to each patient to note down their daily intake of millets. At the end of 6 weeks, HbA1c and lipid profile of each patient was recorded. STATISTICAL ANALYSIS USED: The results of the study were analyzed by nonparametric Wilcoxon's test of significance and nonparametric Kruskal-Wallis test was used.
resultsThere was a significant change in both glycemic control and lipid profile of the study participants. The fasting blood sugar (FBS) for the study participants reduced by more than 20% from 237 ± 50 to 188 ± 33, which is statistically significant with a P < 0.05. Further, there was a 2.7% statistically significant reduction in the HbA1c levels of the study participants.
conclusionsThe intake of millet even in a single meal per day significantly improved the glycemic control, especially the FBS and lipid profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.